Galena Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 89   

Articles published

GALE 2.96 +0.04 (1.37%)
price chart
Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday ...
Galena Biopharma, Inc. (NASDAQ:GALE) , a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that the Company will ...
Related articles »  
MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma ...
Galena Biopharma, Inc. (NASDAQ:GALE) is a Portland, Oregon-based biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.
Galena secures U.S. rights to serotonin blocker (GALE)  Seeking Alpha
Related articles »  
Stocks in Focus - Quicksilver Resources Inc (NYSE:KWK), Galena Biopharma ...
Las Vegas, NV - July 28, 2014 - (TechSonian) �EquityObserver.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Traders Are Watching : Galena Biopharma (NASDAQ:GALE), Potash Corp. of ...  Crazy Joys
Related articles »  
Traders Favorite: Galena Biopharma, Inc. (NASDAQ:GALE), Arena ...
Galena Biopharma, Inc. (NASDAQ:GALE)'s shares fell 2.04% to $2.88. MonoSol Rx, the developer of PharmFilm(R) drug delivery technology, on July 22 announced that it has licensed Zuplenz(R) (ondansetron) to Galena Biopharma, a biopharmaceutical ...
Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for ...
Galena Biopharma, Inc. (NASDAQ:GALE) , a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced the notice of allowance ...
Hot News Stories (07/01/14): Galena Biopharma Inc (GALE), Regeneron ...  Markets Emerging
Related articles »  
Hot News: DARA BioSciences Inc. (NASDAQ:DARA), Galena Biopharma ...
On July 22, 2014, Galena Biopharma Inc. (NASDAQ:GALE), a Delaware corporation and MonoSol Rx, a private specialty pharmaceutical company, entered into a definitive agreement to license the exclusive U.S.
Related articles »  
Notable Runners - Galena Biopharma Inc (GALE), Compania de Minas ...
Galena Biopharma Inc(NASDAQ:GALE) showed no change and closed at $2.94 on a traded volume of 1.66 million shares, in comparison to 3.30 million shares of average trading volume.
Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock
Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology treatments that address major unmet medical needs to advance cancer care.
Why Galena BioPharma Inc (NASDAQ:GALE) Shares Skyrockets Over Biogen ...
Among biotech stocks, Galena BioPharma Inc (NASDAQ:GALE) shares skyrockets 5.7% on Wednesday after CEO Mark Ahn persists to shell out big money for obsolete, rarely prescribed drug products.
Galena Biopharma PT Raised to $8.00 (GALE)  Ticker Report
Galena Biopharma Price Target Increased to $8.00 by Analysts at Roth Capital ...  Watch List News (press release)
Related articles »  
Watch List � Quicksilver Resources Inc (NYSE:KWK), Galena Biopharma Inc ...
Galena Biopharma Inc (NASDAQ:GALE) recently declared it has entered into a definitive agreement to license the U.S. rights for the commercial product Zuplenz(R) (ondansetron) oral soluble film.